Healthcare technology connecting providers, payers, and life sciences
Veradigm is a healthcare technology company providing data, analytics, and software solutions for providers, payers, and life sciences.
AI Panel Score
5 AI reviews
Reviewed
Veradigm's solutions are used by medical practices to manage clinical and administrative operations, including electronic health records, practice management systems, and patient engagement tools. Health plans and payers use Veradigm's analytics products to manage risk adjustment, quality reporting, and pharmacy programs, while life sciences companies use its platforms to support research and analyze real-world evidence. Users typically access these tools through web-based platforms integrated into daily practice or organizational workflows, such as submitting insurance claims, tracking quality metrics, or analyzing patient outcomes data.
Several products have been consolidated into the Veradigm portfolio following acquisitions. Koha Health now operates within Veradigm, providing staffing support, medical coding, and claims submission services. Former Pulse8 solutions, including Calcul8 and Qualit8, are now part of Veradigm Payer Analytics, offering visibility into risk adjustment, quality management, and pharmacy program performance. Babel Health's risk adjustment submission workflow has also been folded into Veradigm Payer Analytics, and the Evalytica platform now operates as the Veradigm Real-World Evidence Analytics Platform, a self-service tool for analyzing real-world healthcare data.
Incorporates cutting-edge artificial intelligence technologies within the Veradigm Network to provide advanced data-driven insights.
Delivers reporting capabilities for staff management, coding, and claims processes as part of the Koha Health integration.
Helps payers analyze and report on quality programs to support high-quality, cost-effective patient care.
Offers visibility into Risk Adjustment, Quality Management, and Pharmacy programs through solutions like Calcul8 and Qualit8.
A self-service analytic platform (formerly Evalytica) that enables life sciences research and analysis of real-world data.
Streamlines workflows, ensures medical coding accuracy, and handles insurance claims submission to improve financial performance.
Provides an end-to-end submissions solution for regional health plans and payers, combining former Babel Health capabilities.
Supports engagement between payers and providers as part of the payer analytics suite.
Provides digital patient record-keeping for medical practices as part of the Veradigm provider technology suite.
Tools carried over from Allscripts that help practices communicate with and engage patients.
Supports administrative and operational functions for independent medical practices to run efficiently.
Connects Veradigm's solutions with external partners, data, and AI technologies to support clinical, financial, and research workflows.
For individual prescribers who want a standalone e-prescribing solution, priced per prescriber.
For small to mid-size ambulatory practices needing a full EHR and practice management platform.
For mid-to-large ambulatory practices, health systems, and payer organizations needing custom EHR, revenue cycle, network, and data solutions; requires contacting Veradigm sales for a tailored quote.
A rollup of six acquisitions selling stability to independent practices, not innovation.
“Veradigm bundles Practice Fusion, Koha Health, Pulse8, and Babel Health into one portfolio. That's a lot of stitching for a board to underwrite with confidence.”
Practice Fusion EHR at $199/month, ePrescribe at $49. Priced like commodity software because it is commodity software — EHR and revenue cycle tools are mature, crowded categories against Epic, athenahealth, and Modernizing Medicine.
Two things stand out. One: this is a rollup — Koha Health, Pulse8, Babel Health, Evalytica all folded in recently, which means integration risk, not product risk. Two: Veradigm had a public accounting scandal and delisted from Nasdaq in 2024. That's not a rumor, that's a fact the board will ask about.
The payer analytics stack (Calcul8, Qualit8, RA submission workflows) is real infrastructure health plans need. But buying from a company mid-reorganization, with no public pricing transparency past the entry tier, is a harder sell than picking athenahealth.
Independent practices already run on this or similar tools; it's parity, not advantage, versus athenahealth.
Board members who read financial news will ask about the delisting before they ask about features.
Practice Fusion is a known, deployable product at $199/month with scheduling and billing included day one.
Solves table-stakes EHR and revenue cycle needs, doesn't advance a differentiated care or data strategy.
Nasdaq delisting and accounting restatement in 2024 are real red flags regardless of underlying revenue.
Small independent practices that just need certified EHR and e-prescribing at a fixed monthly price.
Skip it if your board will ask hard questions about vendor financial stability.
A consolidation play, not a clinical platform — assembled from acquisitions, not built around a care model.
“Veradigm has the breadth to touch every corner of the revenue and quality cycle, but the roadmap reads like an org chart of M&A, not a clinical vision. That's fine for billing. It's a liability for anything touching patient safety.”
Koha Health, Pulse8's Calcul8 and Qualit8, Babel Health, Evalytica — five acquisitions stitched into one 'Network' in what looks like under two years. As a CMO I read that as integration debt, not synergy. Each of those platforms had its own data model and validation logic before Veradigm absorbed it.
Domain fit is split. Practice Fusion EHR at $199/month suits a small ambulatory practice fine for scheduling and e-prescribing, similar to what athenahealth or eClinicalWorks offer at that tier. But 'AI-Powered Insights' with no cited validation study, no clinical evidence trail, and no FDA/CDS transparency noted anywhere in the materials is a governance problem I can't sign off on for anything touching diagnosis or risk stratification.
Three years out: you're locked into a vendor whose core competency is claims and risk-adjustment analytics, not clinical decision support. Fine for revenue cycle. Not where I'd bet care quality infrastructure.
Sits between athenahealth-style EHR vendors and payer analytics firms, without a clear category-leading edge in either.
Matches how independent practices run billing and scheduling, less so how clinicians make bedside decisions.
Veradigm Connect's open APIs and App Expo give real third-party extensibility, similar to Epic's App Orchard model.
Five stitched-together acquisitions (Koha, Pulse8, Babel, Evalytica) create integration and data-lineage risk over time.
Deep on RCM and payer analytics (Payerpath, Payer Analytics); thin, unvalidated AI claims for clinical insight.
Independent practices or regional payers needing consolidated billing, risk-adjustment, and e-prescribing under one vendor.
You need clinically validated AI decision support with transparent evidence, not administrative automation.
$49 ePrescribe is real. Everything above it is a sales call.
“Two tiers priced, one tier hidden behind sales. That third tier is where actual practices and payers end up.”
$49/month for solo ePrescribe. $199/month for the Practice Fusion EHR tier — scheduling, telehealth, RCM bundled in. Fine, transparent, procurement-friendly at that size.
But mid-to-large practices, health systems, payers — the actual Veradigm Network buyers — hit 'Contact Sales.' No published number for Payerpath, Payer Analytics, or RWE Analytics. That's where this company makes its money, and it's also where your 3-year TCO becomes a guess.
50-provider practice on the $199 tier: $199 × 50 × 12 = $119,400/year, before implementation, data migration from legacy Allscripts systems, or clearinghouse fees. Compare to athenahealth or Epic's ambulatory suite — similar sales-call opacity, similar integration tax. No overage rates published anywhere. No stated contract term or renewal window on the enterprise side. Procurement should budget for a negotiation, not a checkout.
Monthly billing on entry tiers is clean; enterprise onboarding friction is unstated.
No published term length or renewal terms for enterprise contracts.
Two tiers listed at $49 and $199, but enterprise/payer pricing is sales-call only.
Quality reporting and risk adjustment metrics are measurable, but no benchmark data provided.
No migration, integration, or clearinghouse fee data for the tier most health systems actually need.
Solo prescribers or small practices needing e-prescribing and EHR at published, monthly pricing.
You need payer analytics or enterprise EHR and want price certainty before a sales call.
Deep portfolio, but stitched together from six acquisitions you'll feel in the seams
“Practice Fusion EHR at $199/month covers scheduling, telehealth, and e-prescribing for small ambulatory practices. The bigger Veradigm Network is powerful on paper but shows its acquisition scars once you're actually charting.”
Koha Health for coding, Pulse8's Calcul8/Qualit8 for payer analytics, Babel Health for risk adjustment submission — all folded into one portfolio. Good for a sales deck, rougher for a biller who has to know which module owns which workflow on a Tuesday afternoon. That's the day-3 problem: five acquisitions under one brand name means inconsistent UI patterns across EHR, RCM, and payer tools.
Compared to Epic or athenahealth, Veradigm's strength is pricing transparency at the low end — $49/month for standalone ePrescribe, $199 for full EHR — but enterprise and payer tiers drop into 'contact sales,' which means no clean quote for anyone comparing options at 4pm before a budget meeting.
AI Patient Scheduling and eChart Courier automation are genuinely useful daily-friction reducers if they work as described. Documentation coverage is thin per the evidence here — no visible docs or API reference pages, which worries me for onboarding new staff mid-quarter.
Acquisition-stitched modules (Koha, Pulse8, Babel Health) suggest inconsistent UX once past the demo.
No docs, API reference, or changelog visible in the evidence — a real gap versus athenahealth's developer resources.
Enterprise/payer tiers require sales contact, no self-serve quote, slowing procurement for busy practices.
Veradigm Network and RWE Analytics Platform (formerly Evalytica) show real depth for payer and life sciences power users.
Practice Fusion EHR bundles scheduling, telehealth, e-prescribing into one workflow at $199/month.
Small to mid-size independent practices wanting an affordable, bundled EHR and e-prescribing solution.
You need a single consistent interface across payer analytics, RCM, and clinical workflows without training staff on multiple legacy systems.
Six product names, one roadmap question mark: is this integration or accumulation?
“Veradigm is Allscripts wearing a new name, stitched together from at least five acquisitions — Koha Health, Pulse8, Babel Health, Evalytica. That's not automatically bad. It's a lot to migrate off of if the parent company stumbles.”
Three tells before the pricing page. One: Calcul8, Qualit8, eChart Courier, Payerpath — five product names in one portfolio, no unified naming, screams post-merger sprawl. Two: no docs, no API reference visible, no changelog. Three: 'AI-Powered Insights' with zero specifics on model or data source — the kind of phrase every EHR vendor slaps on now, from Epic to athenahealth.
Pricing is oddly transparent for enterprise healthcare — $49/month ePrescribe, $199/month full EHR — then drops to 'contact sales' the moment payers or health systems show up. Normal for the category. Still a tell on where the real revenue lives.
Track record concern: Veradigm is Allscripts rebranded, carrying legacy patient engagement tools forward. That's continuity, not innovation. Exit portability is the real worry — once your claims, coding, and risk adjustment data live inside Payerpath and Koha Health, untangling that in 18 months is not a weekend project.
Common questions answered by our AI research team
Veradigm ePrescribe is an affordable, certified e-Prescribing solution that includes support for controlled substances.
Yes. Veradigm offers AI Patient Scheduling to automate and optimize patient scheduling with artificial intelligence.
Yes. Veradigm Connect lets health tech solutions connect with physicians and patients through open APIs, and the App Expo features certified applications and devices built on those APIs for provider practices.
eChart Courier automates electronic chart retrieval, saving time, reducing costs, and increasing efficiency for the medical chart retrieval process.
Yes. Veradigm Payerpath is an all-in-one revenue cycle management solution featuring a top-tier clearinghouse for claims and EDI, alongside risk adjustment support.
